A Significant Increase of Estimated Glomerular Filtration Rate After Switching From Fenofibrate to Pemafibrate in Type 2 Diabetic Patients

BACKGROUND: Dyslipidemia is one of the major risk factors for cardiovascular disease (CVD), along with hypertension, diabetes, smoking and obesity. Approximately 70% of CVD risk remains even after treatment of elevated low-density lipoprotein-cholesterol (LDL-C) by statins. High triglyceride (TG) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanai, Hidekatsu, Katsuyama, Hisayuki, Hakoshima, Mariko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683099/
https://www.ncbi.nlm.nih.gov/pubmed/34970366
http://dx.doi.org/10.14740/cr1333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683099/
https://www.ncbi.nlm.nih.gov/pubmed/34970366
http://dx.doi.org/10.14740/cr1333

Ejemplares similares